Connect with us

Health

Alliance for Global Health and Science 2021 Virtual Institute

Published

on

The Alliance for Global Health and Science (the Alliance) is a partnership between the University of California, Berkeley and Makerere University. The Alliance seeks to make a tangible, enduring impact by focusing on locally identified health research needs and strengthening collaborations between faculty at UC Berkeley and Makerere University.

The Alliance Summer Institute is an opportunity for Makerere University students to learn cutting edge, vital skillsets for bioscience researchers from world class scientists from the University of California system, the Chan Zuckerberg Biohub, SciDIP Global, and Makerere University. This year, the Institute will be held completely virtually, keeping in mind the public health crisis of COVID-19.

If you are interested in participating in the Summer Institute, please fill out this application form which can be found at: https://forms.gle/d1WZVBin3sbfyZdF6

All applications require 1) a letter of interest outlining which course(s) you are interested in participating in, how you will benefit from this coursework, and how you intend on using it to advance your scientific career, and 2) an up-to-date resume listing relevant prerequisites, experience, and coursework with references.

Applications are due by June 30th, 2021 at the latest. The courses being offered this year are as
follows:

  • Introduction to Next Generation Sequencing and Genomic Epidemiology (July 19 – 30)
  • Bioentrepreneurship: Small Molecule Therapeutic and Diagnostic Development (July 19 – 23)
  • Bioinformatics: Covid19 Pandemic Genome Sequence Analysis and Phylogenomics (August 2 – 13)
  • Scientific Diplomacy (August 2 – 13)
  • Concepts and techniques in modern vaccine design for global infectious disease (July 26 – August 6)
  • Scientific Grantwriting & Presentation (August 9 – 13)

Please see Downloads for details.

Health

MNCH e-Post Issue 122: Integrated Intervention Package Increases Health Facility Births – New Study

Published

on

Pregnant woman with midwife. Photo by Iwaria Inc. on Unsplash

By Joseph Odoi

In a significant stride towards improving maternal healthcare outcomes, a recent study conducted by researchers has shown that an integrated intervention consisting of peer support, mobile phone messaging, and provision of mama kits at the household level is successful in increasing the proportion of facility-based births. This groundbreaking research comes at a time when Uganda is still grappling with a very high maternal mortality ratio estimated at 336 deaths per 100,000 live births and neonatal mortality rate also at 22/1000 live births.

In the 2024 BMJ Published study titled “Can an integrated intervention package including peer support increase the proportion of health facility births? A cluster randomized controlled trial in Northern Uganda by researchers namely;  Dr. Victoria Nankabirwa and a team including David Mukunya, Grace Ndeezi, Beatrice Odongkara, Agnes A Arach, Vicentina Achora, Levi Mugenyi, Mohammad Boy Sebit, Julius N Wandabwa, Paul Waako, Thorkild Tylleskär, and James K Tumwine, sought to evaluate the effect of the integrated intervention package on increasing the proportion of health facility births compared to routine government health services. Read More

Click here to View the full MNCH e-Post Issue 122

Continue Reading

Health

CALL for Applications for the SMART4TB Early-Stage Investigator (ESI) Scholar Program

Published

on

CALL for Applications for the SMART4TB Early-Stage Investigator (ESI) Scholar Program.

SMART4TB Early-Stage Investigator (ESI) Scholar Program
Cohort 2 Phase 1 Now Open for Applications
Applications Due March 14 2024
Call for applications

Supporting, Mobilizing, and Accelerating Research for Tuberculosis Elimination (SMART4TB) is an initiative made possible by the generous support of the American people through the United States Agency for International Development (USAID) that aims to transform TB prevention and care. SMART4TB has launched an important capacity strengthening activity, the Early-Stage Investigator (ESI) Training and Mentorship Program. The program’s main objective is to train and support young investigators to develop, implement, and lead their own studies aligned with their national and local TB research priorities.

Investigators within 10 years of receiving their most recent degree or who are new to TB research, based at an institution participating in SMART4TB studies, and supported by their local institutional leadership will be eligible for participation in the program. The program has 4 sequential phases, each with specific eligibility criteria and deliverables required before advancing to the next phase.

Completion of all 4 phases will require the ESI to commit to an intensive training curriculum that includes: 1) Specific courses focused on competencies required for the design, implementation, and analyses of TB research 2) Close 2:1 mentorship from both a local and a SMART4TB faculty research mentor; and 3) Access to technical support consultations from SMART4TB experts.

Progress from one Phase of training to the next Phase will be a competitive process and is not guaranteed. ESI who successfully complete all Phase 1 requirements (Scholars Program) will be eligible to apply and compete for Phase 2 (Fellowship Program). Phase 2 applicants that are approved by SMART4TB and USAID will be required to identify a local senior research mentor. ESI enrolled in Phase 2 will also be matched with a SMART4TB faculty co-mentor. The SMART4TB Training and Mentorship Committee (TMC) will monitor the ESI’s progress throughout the program and assess the quality of the training and mentorship provided to the ESI. In Phase 2, each SMART4TB Fellow will be mentored to develop a full research proposal for which they will serve as lead investigator. ESIs who receive approval and support to initiate their research project can apply for Phase 3 and Phase 4 of the program.

Prerequisite
Phase 1 Eligibility and Application Process ESI interested in applying for Phase 1 of this program must meet the following criteria:

  • Having a PhD as the most recent degree or are new to TB research; and
  • Be from a National TB Program (NTP) or institution/site participating in SMART4TB
  • USAID-approved studies; and
  • Have a letter of support from their local SMART4TB site/institutional leadership (signed on institutional letterhead).

All applications will be reviewed by the SMART4TB ESI Mentorship Advisory Committee. Final selection of Phase 1 participants will require USAID approval. Selected ESI will be notified by email.

The Secretariat, SMART4TB Early-Stage Investigator (ESI) Scholar Program Walimu
Unit 4, Plot 5-7, Coral Crescent
P.O Box 9924 Kampala-Uganda
Deadline for receiving applications: 14th March 2014 by 5pm.
Only short-listed candidates will be contacted.

Additional information
To apply for Phase 1 of this program,
please click: https://jhmi.co1.qualtrics.com/jfe/form/SV_0NiIqASiPJ92GRE
For details about the Phase 1 curriculum and the progress report from the first Cohort, please see the attachments.

For an overview of SMART4TB,
please click here: https://tbcenter.jhu.edu/smart4tb/
For more information about SMART4TB Capacity Strengthening Activities,
please click: https://tbcenter.jhu.edu/wp-content/uploads/2023/03/TA6 Overview.pdf

Continue Reading

Health

Makerere University Research shows challenges facing Forcibly Displaced Persons (FDPs) with Chronic Disease in Northern Uganda

Published

on

Left to Right: Dr. Esther Nanfuka Kalule, a postdoc fellow on this study; Emma Ikwara, a researcher at CHDC; PhD student Onesmus Kamacooko at CHDC and Dr. Ritah Nakanjako interacting after the colloquium.

By Agnes Namaganda

Preliminary findings from a study by Child Health and Development Centre (CHDC) -Makerere University have revealed several challenges faced by Forcibly Displaced Persons (FDPs) with chronic diseases like diabetes, hypertension and cardiovascular diseases. This study is specifically looking at FDPs in northern Uganda. Accessing food, water, medicine, clothing, toilet facilities, privacy and support is a challenge for healthy FDPs but for those with chronic diseases, these provisions may mean the difference between life and death.

According to Drs, Ritah Nakanjako and Esther Nanfuka Kalule, who are post-doc fellows at Makerere University, FDPs with chronic diseases are unable to access facilities with medicines. Speaking at the February monthly colloquium of CHDC, Dr. Nanfuka said, “Medicines and medical forms are sometimes forgotten by these patients yet some do not know the names of their medicines. For others, these medicines get finished along the way due to the abrupt movements.” These disturbances in the continuity of care affects their health and wellbeing.

Left to Right: Dr. Esther Nanfuka, Dr. Ritah Nakanjako, Dr. Godfrey Siu who is giving the presenters feedback about their presentation and Dr. Aggrey Dhabangi.
Left to Right: Dr. Esther Nanfuka, Dr. Ritah Nakanjako, Dr. Godfrey Siu who is giving the presenters feedback about their presentation and Dr. Aggrey Dhabangi.

As an example, she referred to the constant need to monitor blood pressure or blood sugar for these FDPs. “Even when facilities are available, you may not have the money to refill medicines or you may not remember the name of the medicine.” She added that the stress and trauma of this kind of situation usually exacerbates these conditions.

Speaking about the rationale for doing this research, Dr. Nakanjako said that non-communicable diseases (NCDs) are largely unrecognized and inadequately addressed in humanitarian settings, something which the Red Cross calls ‘a neglected crisis’.  Yet, studies conducted among refugees and asylum seekers across the world report a high burden of NCDs. Uganda hosts over 1.5m refugees, the highest proportion in sub-Saharan Africa with the majority comeing from South Sydan.

“The objective of this study is to examine the experiences of FDPs- which will contribute to knowledge on innovative ways of chronic disease care. This will also contribute to the management of NCDs in humanitarian, low resource settings,” Dr. Nakanjako explained.

Dr. Godfrey Siu (Left) and Dr. David Kyaddondo who is the Principal Investigator of this project interacting with other members of CHDC after the CHDC monthly colloquium which takes place every last Wednesday of the month.
Dr. Godfrey Siu (Left) and Dr. David Kyaddondo who is the Principal Investigator of this project interacting with other members of CHDC after the CHDC monthly colloquium which takes place every last Wednesday of the month.

This 5-year study that started in 2022 will run till 2026 and is funded by the Novo Nordisk Foundation under the Mobility-Global Medicine and Research Fund. It is a collaboration between three institutions; Makerere University, the University of Copenhagen, Denmark and the Sudan Centre for Strategic and Policy Studies in South Sudan. This research is taking place in Nyumanzi Reception Center in Adjumani district; Nyumanzi Refugee Settlement also in Adjumani district; IDP Settlements in South Sudan; and the Bidi Bidi Refugee Settlement in Yumbe District.

Other challenges revealed by the FDPs with chronic diseases include the fear of drinking recommended amounts of water before or during travel to manage urine and to avoid stop-overs for security reasons.

After arrival at Nyumanzi Reception Centre in Uganda, these FDPs with chronic diseases do not receive any special care. It is only those with communicable diseases like TB. Cholera or Covid19 that get special care. Other challenges include; “a limited range of drugs, maintenance of cold chains for insulin, rationed water, lack of drinking water, lack of sanitary facilities and the congestion.

Continue Reading

Trending